Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Ethicon Begins Shipping DermaBond Liquid Skin Adhesive In U.S.

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson Ethicon's Aug. 27 launch of Closure Medical's DermaBond topical skin adhesive in the U.S. offers clinicians the first alternative to sutures, staples and strip adhesives for laceration and incision closure, the companies say.

You may also be interested in...



Closure Medical Soothe-N-Seal Canker Sore Product Cleared For OTC Use

Closure Medical is preparing to enter the over-the-counter market with its Soothe-N-Seal canker sore relief product following receipt of FDA 510(k) clearance on Sept. 2.

Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups

Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010555

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel